English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
Focus on tumor gene detection! KingMed and Illumina have reached a new strategic cooperation
2022-07-29
On July 27, Illumina and KingMed Diagnostics Group Co., Ltd. reached a new strategic cooperation on tumor gene detection.
Hologic Reports Gains in Non-COVID Diagnostics, Surgical Products
2022-07-29
Hologic reported after the close of the market on Wednesday that declining sales of COVID-19 assays and difficulties obtaining semiconductor chips contributed to an overall 14 percent year-over-year decline in its fiscal third quarter revenues.
BioGX Gets CE-IVD Mark for Multigene POC COVID-19 Test
2022-07-29
BioGX said on Wednesday that it has obtained CE-IVD marking for a point-of-care, multiplex RT-PCR SARS-CoV-2 assay.
Innovita listed on the SSE STAR Market today
2022-07-28
On July 28, Innovita Biological Technology Co., Ltd. was listed on the SSE STAR Market with the stock code of 688253. Its issue price was CNY 26.06 per share. After the opening, the market value exceeded CNY 4.6 billion.
AstraZeneca to Acquire TeneoTwo in Deal Worth Up to $1.26 Billion
2022-07-28
AstraZeneca's acquisition of TeneoTwo will give the company access to its clinical-stage T-cell engager, TNB-486, strengthening their hematological cancer pipeline.
Roche Launches Dual Antigen and Antibody Hepatitis C Diagnostic Test
2022-07-28
Roche’s new test is the first available immunoassay that allows for simultaneous, independent determination of the hepatitis C virus antigen and antibody status.
Just Now MGI was Approved to be Listed on the Sci-Tech Innovation Board
2022-07-27
On July 26, 2022, China Securities Regulatory Commission approved MGI’s IPO registration on the sci-tech innovation board.
3M Announces Plans to Create Long Term Value Through Spin-Off of Health Care Business
2022-07-27
3M (NYSE: MMM) today announced its intent to spin off its Health Care business, resulting in two world-class public companies well positioned to pursue their respective growth plans.
DiaSorin Gets FDA Clearance for Test to Differentiate Bacterial, Viral Infections
2022-07-27
DiaSorin said Friday it received 501(k) clearance from the US Food and Drug Administration to market its Liaison MeMed BV, a high-throughput immune-response assay that can differentiate between bacterial and viral infections.
Qiagen Reports Strong Non-COVID Sales Growth in Q2; Raises Full-Year Guidance
2022-07-27
Qiagen on Tuesday afternoon reported strong year-over-year sales growth in its core non-COVID-related product portfolio, prompting the company to raise its full-year revenue and earnings guidance even as its COVID-19-related business remains volatile.
A number of IVD companies are listed on the Top 500 China New Economy Enterprise in 2021
2022-07-26
On July 23, 2022, the China Enterprise Evaluation Association released the "2021 China Top 500 New Economy Enterprises" list. China's Top 500 New Economy Enterprises is hosted by the China Enterprise Evaluation Association
Ginkgo Bioworks to Acquire Zymergen for $300M in Stock
2022-07-26
Ginkgo Bioworks said on Monday that it has entered into a definitive agreement to acquire Zymergen in an all-stock deal.
China NMPA Approves GeneMind GenoCare 1600 Sequencer for Noninvasive Prenatal Testing
2022-07-26
Chinese sequencing tech company GeneMind Biosciences said earlier this month that its single-molecule DNA sequencer, GenoCare 1600 (originally developed by Direct Genomics), has been approved by China's National Medical Products Administration (NMPA) for clinical and diagnostic applications.
3 Antigen Detection Kit from Chinese IVD companies were included in the WHO EUL
2022-07-25
Recently, the Wondfo Biotech COVID-19 Antigen Detection Kit (Immunochromatography Method) was included in the WHO (World Health Organization) list for emergency use by the WHO, which can be purchased by other countries and regions.
PamGene Gains CE-IVD Registration for Immunotherapy Guidance Tests
2022-07-25
PamGene International BV said on Thursday that it has obtained CE-IVD registration for its IOpener-NSCLC blood test to help guide immunotherapy in advanced-stage cancer patients.
Total:
3517
Pages:
235
First
Prev
1
..
125
126
127
128
129
130
131
..
235
Next
End